+ All Categories
Home > Documents > Investor & Analyst...

Investor & Analyst...

Date post: 28-Oct-2019
Category:
Upload: others
View: 0 times
Download: 0 times
Share this document with a friend
18
Investor & Analyst Presentation November 17th, 2014 Dr. Cornelius Patt, CEO Andreas Grandinger, CFO
Transcript
Page 1: Investor & Analyst Presentationinvestors.zooplus.com/en/downloads/IR-Presentation_November2014.pdfInvestor & Analyst Presentation November 17th, 2014 Dr. Cornelius Patt, CEO Andreas

Investor & Analyst PresentationNovember 17th, 2014

Dr. Cornelius Patt, CEO

Andreas Grandinger, CFO

Page 2: Investor & Analyst Presentationinvestors.zooplus.com/en/downloads/IR-Presentation_November2014.pdfInvestor & Analyst Presentation November 17th, 2014 Dr. Cornelius Patt, CEO Andreas

Investor Presentation 201411 | page 2

This document includes supplemental financial measures that are or may be non-GAAP financial measures. These supplemental financial measures should not be viewed in isolation as alternatives to measures of zooplus’ financial condition, results of operations or cash flows as presented in accordance with IFRS in its Consolidated Financial Statements. Other companies that report or describe similarly titled financial measures may calculate them differently.

This document contains statements related to our future business and financial performance and future events or developments involving zooplus that may constitute forward-looking statements. We may also make forward-looking statements in other reports, in presentations, in material delivered to stockholders and in press releases. In addition, our representatives may from time to time make oral forward-looking statements. Such statements are based on the current expectations and certain assumptions of zooplus’ management, and are, therefore, subject to certain risks and uncertainties. A variety of factors, many of which are beyond zooplus’ control, affect zooplus’ operations, performance, business strategy and results and could cause the actual results, performance or achievements of zooplus to be materially different from any future results, performance or achievements that may be expressed orimplied by such forward-looking statements or anticipated on the basis of historical trends. Further information about risks anduncertainties affecting zooplus is included throughout our most recent annual and interim reports, which are available on thezooplus website, www.zooplus.de. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results, performance or achievements of zooplus may vary materially from those described in the relevantforward-looking statement as being expected, anticipated, intended, planned, believed, sought, estimated or projected. zooplus neither intends, nor assumes any obligation, to update or revise these forward-looking statements in light of developments whichdiffer from those anticipated.

Due to rounding, numbers presented throughout this and other documents may not add up precisely to the totals provided and percentages may not precisely reflect the absolute figures.

Safe Harbor Statement

Page 3: Investor & Analyst Presentationinvestors.zooplus.com/en/downloads/IR-Presentation_November2014.pdfInvestor & Analyst Presentation November 17th, 2014 Dr. Cornelius Patt, CEO Andreas

Investor Presentation 201411 | page 3

Summary on 9M and Q3 results 2014

€ m

Net sales

Total sales

Gross margin

Total cost ratio

EBITDA

EBT

EBT ratio

9M 2013 9M 2014 delta

292.7 384.8 + 31.5%

306.7 403.4 + 31.5%

34.3% 31.6% - 2.7%p

33.9% 30.1% - 3.8%p

2.0 6.9 + 4.9

1.2 6.1 + 4.9

0.4% 1.5% + 1.1%p

Q3 2013 Q3 2014 delta

102.5 140.0 + 36.6%

107.8 146.4 + 35.8%

33.7% 31.1% - 2.6%p

32.1% 29.2% - 2.9%p

2.0 3.1 + 1.1

1.7 2.8 + 1.1

1.6% 1.9% + 0.3%p

Page 4: Investor & Analyst Presentationinvestors.zooplus.com/en/downloads/IR-Presentation_November2014.pdfInvestor & Analyst Presentation November 17th, 2014 Dr. Cornelius Patt, CEO Andreas

Investor Presentation 201411 | page 4

zooplus strong sales growth will continue and more than € 1.1 bn total sales should be reached already by 2017

Total sales 2010 – 2017e

194257

336

427

> 550

~ 700

~ 900

> 1.100

2010 2011 2012 2013 2014e 2015e 2016e 2017e

+ 63

+ 79

+ 91

in € m,based on organic growth in European countries

32.5% 30.7% 27.1% 30%Total sales growth vs. PY

+ 123

27% 29%

+ 150

+ 200

> 200

22%

New customer sales (1st year)

Repeat customer sales

Total sales

Retention rate93%93%

92%90%

85%79%

81%

Page 5: Investor & Analyst Presentationinvestors.zooplus.com/en/downloads/IR-Presentation_November2014.pdfInvestor & Analyst Presentation November 17th, 2014 Dr. Cornelius Patt, CEO Andreas

Investor Presentation 201411 | page 5

In a large and fragmented niche market zooplus dominates online – and is rapidly catching up with the offline leaders

Market share zooplus and competitors 2014e

~ 50 % market share zooplus online

~ 2 % market share online and offlineCAGR: 2011-14e: 30%

Growth 2014e: 10%

Net sales:

€ 0.5 bn Growth 2014e: 5%

Total net sales:

~ € 1.4 bn

Total pet supplies market Europe (incl. VAT):

~ € 25 bnCAGR: 2011-14e: 2 - 3%

Source: Euromonitor, company information, zooplus estimation; 1 online share of total net sales

Total net sales:

~ € 0.9 bnOnline: € ~ 0.01 bn (< 2%)1

Online: € ~ 0.07 bn (~ 5%)1

Net sales:

~ € 0.2 bn

Page 6: Investor & Analyst Presentationinvestors.zooplus.com/en/downloads/IR-Presentation_November2014.pdfInvestor & Analyst Presentation November 17th, 2014 Dr. Cornelius Patt, CEO Andreas

Investor Presentation 201411 | page 6

481 m EUR (2013)

2.1% of total market

4.2% of specialty market (non-grocery)

Sales incl. VAT / market shares

HU

Source market size: Euromonitor, zooplus estimation, market growth 2%p p.a., BMF;sales growth 2014e rounded to 5% steps

4.4 bn36 m 0.8%

4.8 bn187 m 3.9%

3.4 bn79 m 2.3%

1.6 bn24 m 1.5%

2.5 bn34 m 1.3%

1.8 bn62 m 3.3%

23 bn481 m 2.1%

Total market Size of total market online and offline

Sales zooplus

1.4 bn26 m 1.9%

Market share zooplus

DK, SE, FI

D,A,CH PL, CZ, SK, HU, RO, SI, HR, TR

2.5 bn33 m 1.3%

ES, PT

zooplus is the online market leader in all geographies of Europe – with the widest possible base for further growth

NL, BE, LU

+35%

+50%

+50%

+45%

+30%

+60%

+15%

+30%Sales growth2014e

+30%

Page 7: Investor & Analyst Presentationinvestors.zooplus.com/en/downloads/IR-Presentation_November2014.pdfInvestor & Analyst Presentation November 17th, 2014 Dr. Cornelius Patt, CEO Andreas

Investor Presentation 201411 | page 7

zooplus has constantly improved the cost structure andalready is cost leader in the specialty segment today

4.8% 4.5% 4.5% 3.8%

7.0%5.0% 4.8%

4.2%

22.9%22.9% 21.7%

20.2%

5.8%

4.6%2.5%

1.8%

2011 2012 2013 2014e

33.5%30.0%

IT/Admin / payment (incl. depreciation & interest)

Advertising/Marketing Logistics Personnel

in % of total sales

Source: company data; zooplus estimation; 1) 2013 2) 2012

Cost structure 2011 – 2014e

Pets at Home 42% 1)

Fressnapf Group 38% 2)

Rewe Group 29% 1)

40.5%36.9%

(Grocery channel)

Page 8: Investor & Analyst Presentationinvestors.zooplus.com/en/downloads/IR-Presentation_November2014.pdfInvestor & Analyst Presentation November 17th, 2014 Dr. Cornelius Patt, CEO Andreas

Investor Presentation 201411 | page 8

Strong improvement of KPIs during last 3 years with more to come in next years

2011

Competitive index 0.5 1.0

Gross margin (before advertising) 39% 32%

Share of food 64% 77%

Retention rate 79% 90%

New business (€ m) 100 166

Net growth total sales (€ m) 63 123

Advertising (€ m) 15 10

Gross margin (after advertising) 33% 30%

Operating costs (before advertising) 35% 28%

Total sales ( € m) 257 > 550

Gross profit (after advertising) (€ m) 85 165

Earnings before tax EBT 1 (€ m) - 4 + 8

Strongly increased competitive pressure

Lowered prices (reactive / proactive)

Net growth doubled

Advertising efficiency tripled

Massive efficiency gains and scaling effects

Top line CAGR: 29% p.a.

Gross profit CAGR: 25% p.a.

Maintaining a growth rate of ~ 30% p.a. while achieving in-year-profitability + benchmark retention rates

Excellent basis for future growth and value creation

2014e

Focus on food + right pricing

Retention boost

1 one-off effects of logistics migration adjusted in 2011

Page 9: Investor & Analyst Presentationinvestors.zooplus.com/en/downloads/IR-Presentation_November2014.pdfInvestor & Analyst Presentation November 17th, 2014 Dr. Cornelius Patt, CEO Andreas

Investor Presentation 201411 | page 9

Current outlook shows a strong improvement in sales development

2015e

2016e

2017e

CAGR:2013-17e

~ 700 + 27 %

~ 900 + 29 %

> 1.100 + 22 %

Total sales (€ m)

2014e > 550 + 30 %

EBT (€ m)

8 – 12 1)

12 – 18 1)

20 – 35

~ 8

1) Pre possible one-offs for migration of IT platforms to SAP and Hybris

2013 427 + 27 % vs. PY 3.8

27% p.a. > 50% p.a.

Page 10: Investor & Analyst Presentationinvestors.zooplus.com/en/downloads/IR-Presentation_November2014.pdfInvestor & Analyst Presentation November 17th, 2014 Dr. Cornelius Patt, CEO Andreas

Investor Presentation 201411 | page 10

Current shareholder structure is very much focused on growth and mid-term value creation

November 2014December 2012

Burda 50.04%

Capital Research

7.99%

The Nomad Investment Partnership 7.98%

Ruane, Cunniff & Goldfarb 5.90%

Wasatch Advisors5.39%

Management 4.00%

Others 18.70%Burda 34.30%

Capital Research 7.99%

Ruane, Cunniff& Goldfarb

10.01%

Wasatch Advisors4.99%

Management 5.34%

Others 18.15%

MaxburgBeteiligungen GmbH 14.99%

Deutsche Asset & Wealth 4.23%

Page 11: Investor & Analyst Presentationinvestors.zooplus.com/en/downloads/IR-Presentation_November2014.pdfInvestor & Analyst Presentation November 17th, 2014 Dr. Cornelius Patt, CEO Andreas

Investor Presentation 201411 | page 11

Liquidity in the zooplus stock has increased during 2014

Ø per day€ 176 k

Ø per day vs. 2013

€ 287 k 1.1.-30.6.2014 + 63 %

€ 329 k since 1.7.2014 + 87 %

€ 480 k last 4 weeks + 173 %

2013 2014 Daily tradingvolume in € k

Source: Deutsche Börse, data until 07.11.2014

Page 12: Investor & Analyst Presentationinvestors.zooplus.com/en/downloads/IR-Presentation_November2014.pdfInvestor & Analyst Presentation November 17th, 2014 Dr. Cornelius Patt, CEO Andreas

Investor Presentation 201411 | page 12

zooplus market cap and net sales development since listing in May 2008

Net salesrun-rate in € m

Market capin € m

0,8 0,5 0,5 1,0 0,6 0,6 0,6Ø Market capp.a. / net sales

Ø last 4 weeks:0,7

Source: zooplus data; Deutsche Börse, data until 07.11.2014

Page 13: Investor & Analyst Presentationinvestors.zooplus.com/en/downloads/IR-Presentation_November2014.pdfInvestor & Analyst Presentation November 17th, 2014 Dr. Cornelius Patt, CEO Andreas

Investor Presentation 201411 | page 13

zooplus: a winning investment case

Successful development in 2014: sales 30% up, cost ratio at 30%, EBT up > 100%

Balanced shareholder structure – increased liquidity in the zooplus stock

Strong balance sheet for further growth – high return on capital

Market of € 25 bn leaves great potential – closing the gap towards the No. 1 in Europe

Committed management board with 5% in the capital of the company

Excellent outlook:

zooplus : prepared for strong value creation for investors

Superlinear growth 27 % p.a.

Total sales > € 1 bn in 2017

EBT CAGR until 2017 > 50% p.a.

Page 14: Investor & Analyst Presentationinvestors.zooplus.com/en/downloads/IR-Presentation_November2014.pdfInvestor & Analyst Presentation November 17th, 2014 Dr. Cornelius Patt, CEO Andreas

Investor Presentation 201411 | page 14

Backup: Key Financials

Page 15: Investor & Analyst Presentationinvestors.zooplus.com/en/downloads/IR-Presentation_November2014.pdfInvestor & Analyst Presentation November 17th, 2014 Dr. Cornelius Patt, CEO Andreas

Investor Presentation 201411 | page 15

Backup: Key Financials Q3 2014

» Total sales up 36%, adding € 38.6 m on prior year period

» Significantly increased efficiency in logistics (-1.4%p), customer acquisition (-0.3%p) and personnel (-0.8%p)

» Total cost ratio of 29.2% (previous year 32.1%)

P&Lin € m

Q3 2014 Q3 2013 ∆∆∆∆ abs ∆∆∆∆%

Total sales 146.4 107.8

abs. 38.6

∆ in % 35.8%

COGS100.8

68.9%71.5

66.3%

29.3

2.6%p

Logistics29.2

19.9%23.0

21.3%

6.2

-1.4%p

Payment1.6

1.1%1.6

1.4%

0.0

-0.3%p

Customer acquisition2.6

1.8%2.3

2.1%

0.3

-0.3%p

Personnel5.1

3.5%4.6

4.3%

0.5

-0.8%p

G&A3.9

2.7%2.9

2.7%

1.0

0.0%p

EBITDA3.1

2.1%2.0

1.9%

1.1

0.2%p

I&DA0.3

0.2%0.3

0.3%

0.0

-0.1%p

EBT2.8

1.9%1.7

1.6%

1.1

0.3%p

Page 16: Investor & Analyst Presentationinvestors.zooplus.com/en/downloads/IR-Presentation_November2014.pdfInvestor & Analyst Presentation November 17th, 2014 Dr. Cornelius Patt, CEO Andreas

Investor Presentation 201411 | page 16

Profit & Loss 9M 2014

in € m9M 2014 9M 2013

abs % abs %

Sales 384.8 95.4% 292.7 95.5%

Other income 18.6 4.6% 14.0 4.5%

Total sales 403.4 100.0% 306.7 100.0%

Cost of materials -276.0 -68.4% -201.4 -65.7%

Personnel costs -15.6 -3.9% -13.8 -4.5%

Depreciation -0.5 -0.1% -0.5 -0.2%

Other expenses -104.8 -26.0% -89.5 -29.2%

thereof logistics / fulfillment (-81.9) -20.3% (-67.3) -22.0%

thereof marketing (-7.0) -1.7% (-8.3) -2.7%

thereof payment (-4.9) -1.2% (-4.4) -1.4%

thereof other costs (-11.0) -2.7% (-9.4) -3,1%

Earnings before interest and taxes (EBIT) 6.4 1.6% 1.4 0.5%

Financial income 0.0 0.0% 0.0 0.0%

Financial expenses -0.3 -0.1% -0.3 -0.1%

Earnings before taxes (EBT) 6.1 1.5% 1.2 0.4%

Taxes on income -2.3 -0.6% -0.9 -0.3%

Consolidated net result 3.8 0.9% 0.3 0.1%

Differences from currency translation 0.0 0.0% 0.1 0.0%

Hedge reserve 1.3 0.3% 0.1 0.0%

Items that may be relclassified subsequently to profit orloss

1.4 - 0.2 -

Comprehensive income 5.2 1.3% 0.4 0.1%

Earnings per share in €

basic 0.62 - 0.05 -

diluted 0.60 - 0.04 -

Page 17: Investor & Analyst Presentationinvestors.zooplus.com/en/downloads/IR-Presentation_November2014.pdfInvestor & Analyst Presentation November 17th, 2014 Dr. Cornelius Patt, CEO Andreas

Investor Presentation 201411 | page 17

Balance Sheet as of Sep. 30th, 2014

Assets Equity and Liabilities

in € m Sep. 30th, 2014 Dec. 31st, 2013 ∆∆∆∆ abs

A. Non-current assets

I. PP&E 0.8 0.5 0.3

II. Intangible assets 7.6 4.9 2.7

III. Financial assets 0.0 0.0 0.0

IV. Deferred tax assets 5.0 6.9 -1.9

Total non-current assets 13.4 12.5

B. Current assets

I. Inventories 57.6 43.7 13.9

II. Advance payments 5.4 0.3 5.1

III. Trade receivables 12.5 10.8 1.7

IV. Other current assets 6.9 10.9 -4.0

V.Derivative financialinstruments

2.0 0.0 2.0

VI. Cash and cash equivalents 11.8 5.6 6.2

Total current assets 96.2 71.3

109.6 83.7 25.9

in € m Sep. 30th, 2014 Dec. 31st, 2013 ∆∆∆∆ abs

A. Equity

I. Capital subscribed 6.4 6.1 0.3

II. Capital reserves 55.4 50.3 5.1

III. Other reserves 1.4 0.0 1.4

IV. Profit and Loss carried forward -15.9 -19.7 3.8

Total equity 47.3 36.7

B. Non-current liabilities 1.0 0.5

C. Current liabilities

I. Trade payables 16.0 16.2 -0.2

II. Financial liabilities 19.0 13.0 6.0

III. Derivative financial instruments 0.1 0.1 0.0

IV. Other current liabilities 19.5 12.7 6.8

V. Tax liabilites 1.6 0.8 0.8

VI. Provisions 3.8 2.7 1.1

VII. Deferred income 1.3 1.0 0.3

Total current liabilities 61.3 46.5

109.6 83.7 25.9

Page 18: Investor & Analyst Presentationinvestors.zooplus.com/en/downloads/IR-Presentation_November2014.pdfInvestor & Analyst Presentation November 17th, 2014 Dr. Cornelius Patt, CEO Andreas

Investor Presentation 201411 | page 18

Cash Flow 9M 2014

EBT 6.1 1.2

Cash flow from operating activities -0.9 -2.9

Cash flow from investing activities -3.4 -3.3

Cash flow from financing activities 10.4 10.7

Net change of cash and cash equivalents 6.1 4.6

Cash on hand, bank deposits, cheques 11.8 7.6

in € m 9M 2014 9M 2013


Recommended